Shasun Pharmaceuticals has more than doubled its net profit at Rs.22.2 crore during the fourth quarter ended March 31, 2015, against Rs.10.4 crore reported in the corresponding quarter of the previous year. This is despite 3 per cent drop in turnover at Rs.336.1 crore for the quarter from Rs.346.6 crore in the fourth quarter of 2013-14. A company release says formulations business delivered robust growth in 2014-15 led by a strong performance in the regulated markets.
Business Line
· World's no.1 skincare brand Bepanthen* launches in India, as a solution to tackle India's widespread dry skin…
By Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital.…
Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Winter weather brings a host…
By Dr. Naveen Ganjoo, Senior Consultant - Hepatology & Integrated Liver Care, Aster RV Hospital…
Under the Production Linked Incentive(PLI)scheme, Lyfius Pharma Private Limited(LyfiusPharma) invested ₹2,500 crores in Penicillin-G( Pen-G)facility…
Coimbatore, October 30, 2024: Sri Ramakrishna Hospital’s Neurology experts observes “World Stroke Day” on October…